SLRX - Salarius Pharmaceuticals, Inc.
0.771
-0.009 -1.167%
Share volume: 23,026
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.78
-0.01
-0.01%
Summary score
17%
Profitability
8%
Dept financing
3%
Liquidity
58%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.15%
Return on assets
-21.19%
Return on sales
-2448.55%
Return on invested capital
157.02%
Total debt ratio
14.21%
Debt ratio change over timeo
0%
Current Ratio
7.84%
Quick Ratio
8.74%
Cash Position Ratio
5.32%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.46%
Return on assets
-8.93%
Return on sales
0%
Return on invested capital
-24.8%
Total debt ratio
9.92%
Debt ratio change over timeo
0%
Current Ratio
5.59%
Quick Ratio
0%
Cash Position Ratio
4.06%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.33%
Return on assets
-7.62%
Return on sales
0%
Return on invested capital
-25.67%
Total debt ratio
10.65%
Debt ratio change over time
0%
Current Ratio
5.66%
Quick Ratio
0%
Cash Position Ratio
3.89%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLRX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -25.15% | 18.71% | 4.67% | 19.62% |
| Return on assets | -21.19% | 3.4% | 3.32% | 11.24% |
| Return on sales | -2448.55% | 24.27% | 25.81% | 41.89% |
| Return on invested capital | 157.02% | 5.38% | 4.17% | -280.52% |
| Profitability | 25% | 47% | 29% | 75% |
| Total debt ratio | 14.21% | 78.91% | 58.54% | 54.01% |
| Debt ratio change over time | 0% | 0% | 10.69% | 0% |
| Dept financing | 5% | 25% | 44% | 17% |
| Current Ratio | 5.59% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 4.06% | 0.21% | 0.6% | 0.32% |
| Liquididy | 75% | 9% | 11% | 8% |
| Short-term ratios | SLRX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -9.46% | 41.05% | 6.87% | 16.13% |
| Return on assets | -8.93% | 3.67% | 3.13% | 8.75% |
| Return on sales | 0% | 26.16% | 24.75% | 38.84% |
| Return on invested capital | -24.8% | 9.43% | 5.58% | -6.74% |
| Profitability | 0% | 77% | 44% | 60% |
| Total debt ratio | 9.92% | 91.28% | 61.3% | 55.02% |
| Debt ratio change over time | 0% | 0% | 13.89% | 0% |
| Dept financing | 3% | 25% | 42% | 15% |
| Current Ratio | 5.59% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 4.06% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 29% | 35% | 25% |
